Iridian Asset Management LLC CT boosted its position in shares of Herbalife Ltd. (NYSE:HLF - Free Report) by 43.7% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 2,228,193 shares of the company's stock after acquiring an additional 677,739 shares during the quarter. Herbalife comprises about 3.4% of Iridian Asset Management LLC CT's portfolio, making the stock its 12th largest position. Iridian Asset Management LLC CT owned about 2.23% of Herbalife worth $16,021,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. GAMMA Investing LLC raised its stake in shares of Herbalife by 465.3% during the 2nd quarter. GAMMA Investing LLC now owns 3,533 shares of the company's stock valued at $37,000 after buying an additional 2,908 shares during the last quarter. nVerses Capital LLC raised its stake in shares of Herbalife by 240.0% during the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company's stock valued at $53,000 after buying an additional 3,600 shares during the last quarter. Public Employees Retirement System of Ohio raised its stake in shares of Herbalife by 22.9% during the 1st quarter. Public Employees Retirement System of Ohio now owns 5,558 shares of the company's stock valued at $56,000 after buying an additional 1,035 shares during the last quarter. Carolina Wealth Advisors LLC purchased a new position in shares of Herbalife during the 3rd quarter valued at about $78,000. Finally, Van ECK Associates Corp raised its stake in shares of Herbalife by 10.3% during the 2nd quarter. Van ECK Associates Corp now owns 8,684 shares of the company's stock valued at $90,000 after buying an additional 808 shares during the last quarter.
Analyst Ratings Changes
A number of research firms have weighed in on HLF. StockNews.com lowered Herbalife from a "buy" rating to a "hold" rating in a research note on Tuesday, October 22nd. B. Riley cut their price target on Herbalife from $17.00 to $12.00 and set a "buy" rating for the company in a research note on Thursday. Citigroup cut their price target on Herbalife from $16.00 to $13.00 and set a "buy" rating for the company in a research note on Friday, October 25th. Finally, DA Davidson cut their price target on Herbalife from $13.00 to $7.50 and set a "neutral" rating for the company in a research note on Thursday. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $10.75.
View Our Latest Stock Report on Herbalife
Insider Transactions at Herbalife
In related news, Director Juan Miguel Mendoza purchased 10,000 shares of the company's stock in a transaction dated Monday, September 9th. The stock was acquired at an average cost of $7.11 per share, for a total transaction of $71,100.00. Following the completion of the transaction, the director now directly owns 120,000 shares of the company's stock, valued at approximately $853,200. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.94% of the company's stock.
Herbalife Price Performance
HLF stock traded up $0.73 during trading on Thursday, hitting $7.54. The stock had a trading volume of 9,773,990 shares, compared to its average volume of 2,102,439. Herbalife Ltd. has a twelve month low of $6.59 and a twelve month high of $15.66. The stock has a market capitalization of $758.91 million, a P/E ratio of 9.21, a PEG ratio of 0.26 and a beta of 1.19. The company's 50-day moving average price is $7.35 and its two-hundred day moving average price is $9.30.
Herbalife (NYSE:HLF - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.38. Herbalife had a negative return on equity of 18.69% and a net margin of 1.63%. The company had revenue of $1.24 billion for the quarter, compared to analysts' expectations of $1.23 billion. As a group, sell-side analysts expect that Herbalife Ltd. will post 1.34 EPS for the current fiscal year.
Herbalife Profile
(
Free Report)
Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.
See Also
Before you consider Herbalife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Herbalife wasn't on the list.
While Herbalife currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.